KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Danaher (DHR) Research & Development (2016 - 2026)

Danaher has reported Research & Development over the past 18 years, most recently at $387.0 million for Q1 2026.

  • For Q1 2026, Research & Development rose 2.11% year-over-year to $387.0 million; the TTM value through Mar 2026 reached $1.6 billion, up 0.69%, while the annual FY2025 figure was $1.6 billion, 0.88% up from the prior year.
  • Research & Development for Q1 2026 was $387.0 million at Danaher, down from $438.0 million in the prior quarter.
  • Over five years, Research & Development peaked at $442.0 million in Q4 2024 and troughed at $236.0 million in Q4 2022.
  • A 5-year average of $388.2 million and a median of $387.0 million in 2026 define the central range for Research & Development.
  • On a YoY basis, Research & Development climbed as much as 72.46% in 2023 and fell as far as 16.24% in 2023.
  • Year by year, Research & Development stood at $236.0 million in 2022, then soared by 72.46% to $407.0 million in 2023, then rose by 8.6% to $442.0 million in 2024, then decreased by 0.9% to $438.0 million in 2025, then fell by 11.64% to $387.0 million in 2026.
  • Business Quant data shows Research & Development for DHR at $387.0 million in Q1 2026, $438.0 million in Q4 2025, and $378.0 million in Q3 2025.